OPKO HEALTH INC
For the period ended Mar 31, 2024. Filed May 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 7, 2024
OPK$1.710.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Equity
CONSOLIDATED STATEMENTS OF EQUITY
(In thousands, except share data)
For the three months ended March 31, 2024
| Accumulated | ||||||||
|---|---|---|---|---|---|---|---|---|
| Additional · Other | ||||||||
| Common Stock · Treasury · Paid-In · Comprehensive · Accumulated | ||||||||
| Shares | Dollars | Shares | Dollars | Capital | Loss | Deficit | Total | |
| Balance at December 31, 2023 | 781,936,885 | $7,820 | (8,655,082) | $(1,791) | $3,433,006 | $(38,030) | $(2,011,786) | $1,389,219 |
| Equity-based compensation expense | — | — | — | — | — | — | — | — |
| Exercise of common stock options and warrants | — | — | — | — | 2,590 | — | — | 2,590 |
| 2025 convertible notes | — | — | (21,117,671) | — | — | — | — | — |
| Share Repurchase | (55,145,031) | (551) | — | — | (49,449) | — | — | (50,000) |
| Net loss | — | — | — | — | — | — | (81,836) | (81,836) |
| Other comprehensive loss | — | — | — | — | — | (7,165) | — | (7,165) |
| Balance at March 31, 2024 | 726,791,854 | $7,269 | (29,772,753) | $(1,791) | $3,386,147 | $(45,195) | $(2,093,622) | $1,252,808 |
CONSOLIDATED STATEMENTS OF EQUITY
(In thousands, except share data)
For the three months ended March 31, 2023
| Accumulated | ||||||||
|---|---|---|---|---|---|---|---|---|
| Additional · Other | ||||||||
| Common Stock · Treasury · Paid-In · Comprehensive · Accumulated | ||||||||
| Shares | Dollars | Shares | Dollars | Capital | Loss | Deficit | Total | |
| Balance at December 31, 2022 | 781,306,164 | $7,813 | (8,655,082) | $(1,791) | $3,421,872 | $(43,323) | $(1,822,923) | $1,561,648 |
| Equity-based compensation expense | — | — | — | — | 2,717 | — | — | 2,717 |
| Net loss | — | — | — | — | — | — | (18,267) | (18,267) |
| Other comprehensive income | — | — | — | — | — | 5,712 | — | 5,712 |
| Balance at March 31, 2023 | 781,306,164 | $7,813 | (8,655,082) | $(1,791) | $3,424,589 | $(37,611) | $(1,841,190) | $1,551,810 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.